This Artificial Intelligence (AI) Cloud Stock Has Crushed Amazon, Microsoft, and Google in 2026. It Can Continue Skyrocketing After 184% Gains

DigitalOcean said AI-focused annual recurring revenue jumped 221% year over year to $170 million in Q1, while inference-services ARR surged 487% and management raised the outlook to 26% revenue growth in 2026 and more than 50% in 2027. The article argues the stock still has meaningful upside, citing a potential 141% gain if revenue reaches $3.53 billion by 2030 and the shares re-rate to 10 times sales. Overall, the piece is a bullish growth-and-valuation call on AI inference demand rather than a near-term earnings event.

Analysis

DOCN is functioning less like a generic cloud provider and more like a leveraged call option on inference spend migrating out of hyperscaler ecosystems. The second-order implication is that AI workloads are fragmenting by use case: training remains a scale game for AMZN/MSFT/GOOGL, while inference becomes an efficiency game where simpler tooling, lower switching costs, and predictable unit economics matter more than raw breadth. That creates a lane for DOCN to keep taking share from smaller teams that were priced out of hyperscaler complexity, even if the total cloud market remains dominated by the incumbents.

The market is likely underappreciating how much of DOCN’s upside is operating leverage rather than just revenue growth. If inference truly becomes the majority of AI compute, the company’s product mix should skew toward higher-frequency consumption and better retention, which can expand ARR quality faster than headline growth suggests. The risk is that the current valuation is already discounting several years of flawless execution; any deceleration in AI ARR or a sign that customers prototype on DOCN but scale back to hyperscalers would hit the multiple hard before fundamentals fully roll over.

For the megacap clouds, DOCN’s success is not immediately earnings-threatening, but it is strategically relevant: it validates a market segment where hyperscalers are too complex or too expensive for the edge of the demand curve. That said, the biggest contrarian risk is that investors are extrapolating inference demand too linearly; inference economics can compress quickly if model efficiency improves or if GPU supply normalization cuts the scarcity premium. In that scenario, the growth story stays intact but the stock could derate violently because it is trading on long-duration expectations, not current cash generation.

Key Decisions for Investors

• Long DOCN on a 3-6 month horizon, but use staged entries on 5-8% pullbacks; risk/reward is favorable only if AI ARR keeps compounding above 100% and management sustains the 2027 guide.
• Buy DOCN calls or call spreads 6-9 months out to express upside with defined risk; prefer structures that monetize continued multiple support while limiting damage if inference growth normalizes.
• Pair trade: long DOCN / short a basket of high-multiple software names with weaker AI monetization; the thesis is that infrastructure-native AI beneficiaries should outperform pure narrative AI exposure over the next two quarters.
• Avoid shorting MSFT/AMZN/GOOGL outright on this headline; the better expression is relative underperformance if DOCN is taking the low-complexity edge of the market, not a collapse in hyperscaler demand.
• Set a review trigger if DOCN AI ARR growth falls below 100% or inference mix stalls for two consecutive quarters; that is the point where the multiple likely compresses faster than revenue can cushion it.